Skip metastasis in osteosarcoma

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 10, 2003, Pages 806-808

  Leavey, Patrick J ^a,c   Day, Michael D ^b   Booth, Timothy ^a,c   Maale, Gerhard ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d Presbyterian Medical Center of Dallas   (United States)

Author keywords

Metastasis; Osteosarcoma; Pediatrics

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE;

ADOLESCENT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CASE REPORT; CHILD; HUMAN; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; BONE NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROGNOSIS;

EID: 0141889042     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200310000-00013     Document Type: Article

References (15)

1. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-790.
2. Enneking WF, Kagan A. The implications of "skip" metastases in osteosarcoma. Clin Orthop. 1975;33-41.
3. Malawer MM, Dunham WK. Skip metastases in osteosarcoma: recent experience. J Surg Oncol. 1983;22:236-245.
4. Aung L, Gorlick R, Healey JH, et al. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J Clin Oncol. 2003;21:342-348.
5. Ferguson WS, Harris MB, Goorin AM, et al. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma. Pediatric Oncology Group Trial. J Pediatr Hematol Oncol. 2001;23:340-348.
6. Enneking WF, Kagan A. "Skip" metastases in osteosarcoma. Cancer. 1975;36:2192-2205.
7. Simon MA, Aschliman MA, Thomas N, et al. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg [Am]. 1986;68:1331-1337.
8. Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastasis. J Bone Joint Surg [Am]. 1990;72:60-68.
9. Meyers PA, Heller G, Healey JH, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol. 1993;11: 449-453.
10. Picci P, Sangiorgi L, Bahamonde L, et al. Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities. Ann Oncol. 1997;8:899-903.
11. Goorin AM, Harris MB, Bernstein M, et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol. 2002;20:426-433.
12. Schreiman JS, Crass JR, Wick MR, et al. Osteosarcoma: role of CT in limb-sparing treatment. Radiology. 1986;161:485-488.
13. Sundaram M, McGuire MH, Herbold DR, et al. Magnetic resonance imaging in planning limb-salvage surgery for primary malignant tumors of bone. J Bone Joint Surg [Am]. 1986;68:809-819.
14. Hudson TM, Hamlin DJ, Enneking WF, et al. Magnetic resonance imaging of bone and soft tissue tumors: early experience in 31 patients compared with computed tomography. Skeletal Radiol. 1985;13:134-146.
15. Zimmer WD, Berquist TH, McLeod RA, et al. Bone tumors: magnetic resonance imaging versus computed tomography. Radiology. 1985;155: 709-718.